PRECISION BIOSCIENCES INC DTIL
COM NEW · Common Stock · CUSIP 74019P207
American gene editing company
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersDurham, NC
- Websiteprecisionbiosciences.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 6.9m as of 2024-03-21, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $13.54. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).
Biggest buyers
| TANG CAPITAL MANAGEMENT LLC | New | +589.6k |
| JANUS HENDERSON GROUP PLC | New | +573.1k |
| PERCEPTIVE ADVISORS LLC | New | +480.5k |
| Aquilo Capital Management, LLC | New | +385.4k |
| VANGUARD GROUP INC | New | +260.8k |
| Alyeska Investment Group, L.P. | New | +250.0k |
| ACADIAN ASSET MANAGEMENT LLC | New | +114.3k |
| RENAISSANCE TECHNOLOGIES LLC | New | +99.5k |
| CITADEL ADVISORS LLC | New | +97.3k |
| Moloney Securities Asset Management, LLC | New | +54.2k |
Biggest sellers
| None |
Biggest calls
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Octagon Capital Advisors LP 13G · institution new · filed 2026-02-10 | 10.0% |
| Readout Capital, LP 13G · passive investor +0.5 pts · filed 2025-08-14 | 9.4% |
| Aberdeen Group plc 13G · institution new · filed 2026-01-27 | 8.9% |
| Bleichroeder LP 13G · institution -1.5 pts · filed 2026-02-13 | 8.2% |
| Lynx1 Capital Management LP 13G · passive investor +1.3 pts · filed 2026-07-20 | 5.4% |
| BlackRock, Inc. 13G · institution new · filed 2026-10-27 | 5.0% |
Fell to 5% or below in the last year: Weinstein Benjamin (4.0%, 2026-08-24), Empery Asset Management, LP (5.0%, 2026-07-29), TANG CAPITAL MANAGEMENT LLC (0.0%, 2026-02-17)
Insider purchases and sales in Q1 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2022 | 1 | $50.7k | 3 | $75.4k | — |
| Q3 2022 | 1 | $59.7k | 0 | — | — |
| Q4 2022 | 0 | — | 1 | $14.5k | — |
| Q1 2023 | 1 | $17.2k | 3 | $61.7k | $38.5k |
| Q2 2023 | 0 | — | 2 | $16.2k | $16.2k |
| Q3 2023 | 1 | — | 0 | — | — |
| Q4 2023 | 0 | — | 2 | — | — |
| Q1 2024 | 0 | — | 4 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2024-01-23 | SMITH J. JEFFERSON Chief Research Officer | Sold | —28.0k shares |
| 2024-01-22 | List Alan Chief Medical Officer | Sold plan | —21.5k shares |
| 2024-01-22 | Scimeca Dario General Counsel and Secretary | Sold plan | —21.3k shares |
| 2024-01-22 | Amoroso Michael President and CEO, director | Sold plan | —137.4k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| TANG CAPITAL MANAGEMENT LLC 0.83% of their portfolio | 589.6k $8.0m | New |
| JANUS HENDERSON GROUP PLC 0.00% of their portfolio | 573.1k $7.7m | New |
| PERCEPTIVE ADVISORS LLC 0.11% of their portfolio | 480.5k $6.5m | New |
| Aquilo Capital Management, LLC 3.92% of their portfolio | 385.4k $5.2m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 260.8k $3.5m | New |
| Alyeska Investment Group, L.P. 0.02% of their portfolio | 250.0k $3.4m | New |
| ACADIAN ASSET MANAGEMENT LLC 0.01% of their portfolio | 114.3k $1.5m | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 99.5k $1.3m | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 97.3k $1.3m | New |
| Moloney Securities Asset Management, LLC 0.11% of their portfolio | 54.2k $734.9k | New |
| STIFEL FINANCIAL CORP 0.00% of their portfolio | 39.9k $540.6k | New |
| MORGAN STANLEY 0.00% of their portfolio | 35.3k $478.4k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 29.8k $404.8k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 28.4k $385.3k | New |
| BlackRock Inc. 0.00% of their portfolio | 26.4k $358.0k | New |
| Tejara Capital Ltd 0.12% of their portfolio | 24.8k $335.8k | New |
| Blue Owl Capital Holdings LP 0.05% of their portfolio | 20.2k $274.2k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 17.0k $231.0k | New |
| Corient Private Wealth LP 0.00% of their portfolio | 11.9k $161.1k | New |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.00% of their portfolio | 11.5k $156.6k | Not comparable |
| Curi Capital, LLC 0.00% of their portfolio | 11.3k $153.7k | New |
| GSA CAPITAL PARTNERS LLP 0.01% of their portfolio | 10.1k $137.0k | New |
| Amundi 0.00% of their portfolio | 8.5k $91.3k | New |
| Allworth Financial LP 0.00% of their portfolio | 4.8k $64.7k | New |
| Vivo Capital, LLC 0.00% of their portfolio | 4.7k $63.4k | New |
| BARCLAYS PLC 0.00% of their portfolio | 2.9k $39.0k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1.9k $25.7k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 861 $11.7k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 389 $5.3k | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) 0.00% of their portfolio | 353 $4.8k | New |
| UBS Group AG 0.00% of their portfolio | 206 $2.8k | New |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 152 $2.1k | New |
| TOTH FINANCIAL ADVISORY CORP 0.00% of their portfolio | 100 $1.4k | New |
| NewEdge Advisors, LLC 0.00% of their portfolio | 48 $644 | New |
| Ameliora Wealth Management Ltd. 0.00% of their portfolio | 33 $447 | New |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 14 $190 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 9 $0 | New |
| Investors Research Corp 0.00% of their portfolio | 8 $108 | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 5 $68 | New |
| TSFG, LLC 0.00% of their portfolio | 3 $0 | New |
| FMR LLC 0.00% of their portfolio | 2 $27 | New |
| CITIGROUP INC 0.00% of their portfolio | 1 $14 | New |
| GPS Wealth Strategies Group, LLC 0.00% of their portfolio | 1 $14 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |